Cheng F. Yuan
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Functional Role of ALKBH5 in Kidney Injury: Insights Into Mechanisms and Therapeutic Potential.
Journal: Journal of cellular biochemistry
Published: June 13, 2026
Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets.
Journal: Annals of medicine
Published: May 27, 2026
Enhanced detection of bladder cancer using combined circulating tumor cells, urine-derived epithelial cells, and molecular biomarkers.
Journal: Journal of cancer research and clinical oncology
Published: February 08, 2026
Editorial: Mechanisms and therapeutic strategies in cellular injury and repair.
Journal: Frontiers in cell and developmental biology
Published: January 16, 2026
Targeting PSAT1 in diabetic kidney disease: a ferroptosis-driven strategy for precision therapy.
Journal: Molecular and cellular biochemistry
Published: November 19, 2025
LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradation.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 19, 2025
Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.
Journal: Journal of cellular and molecular medicine
Published: June 24, 2025
UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway
Journal: Endocrine, metabolic & immune disorders drug targets
Published: April 29, 2025
EphrinB2 alleviates tubulointerstitial fibrosis in diabetic kidney disease.
Journal: Journal of translational medicine
Published: April 21, 2025
Deciphering cellular heterogeneity and pathway dynamics in urinary samples: a UMAP-Based approach to understanding acute kidney injury.
Journal: Frontiers in pharmacology
Published: February 11, 2025
Integrative approaches to depression in end-stage renal disease: insights into mechanisms, impacts, and pharmacological strategies.
Journal: Frontiers in pharmacology
Published: January 14, 2025
CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma.
Journal: Frontiers in pharmacology
Published: January 14, 2025
Last Updated: 09/26/2026